Exelixis (EXEL) Total Current Liabilities (2010 - 2026)

Exelixis (EXEL) recorded quarterly Total Current Liabilities of $371.0 million in Q2 2026, down 8.55% quarter-over-quarter from $405.6 million in Q1 2026, and down 7.05% on a YoY basis from $399.1 million in Q2 2025.

Exelixis (EXEL) Total Current Liabilities (2010 - 2026) Analysis & Trends

Exelixis' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $371.0 million for Q2 2026.

  • In Q2 2026, Total Current Liabilities fell 7.05% year-over-year to $371.0 million; the TTM figure through Apr 2026 stood at $371.0 million (down 7.05% YoY), while the FY2026 annual figure was $405.6 million, changed 0.46% from the prior year.
  • Total Current Liabilities was $371.0 million for Q2 2026 at Exelixis, down from $405.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $405.6 million in Q1 2026 to a low of $289.1 million in Q2 2022.
  • Historically, Total Current Liabilities has averaged $356.5 million across 5 years, with a median of $371.0 million in 2026.
  • The sharpest annual moves came in 2022 and 2026: Total Current Liabilities surged 35.5% in 2022, then dropped 7.05% in 2026.
  • A 5-year view of Total Current Liabilities shows it stood at $324.4 million in 2022, then advanced by 21.56% to $394.3 million in 2023, then climbed by 0.02% to $394.3 million in 2024, then declined by 5.22% to $373.8 million in 2025, then fell by 0.75% to $371.0 million in 2026.
  • The last three Total Current Liabilities figures came in at $371.0 million (Q2 2026), $405.6 million (Q1 2026), and $373.8 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 1.70 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 16.35 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 636.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 13.42 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 3.88 Bn
9 Abivax 94.37 Bn 94.37 Bn - 72.86 Mn
10 Exelixis 13.37 Bn 12.59 Bn 590.86 Mn 370.98 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 370.98 Mn
Jan 2, 2026 405.64 Mn
Oct 3, 2025 373.78 Mn
Jul 4, 2025 336.11 Mn
Apr 4, 2025 399.10 Mn
Jan 3, 2025 403.77 Mn
Sep 27, 2024 394.35 Mn
Jun 28, 2024 345.70 Mn
Mar 29, 2024 373.01 Mn
Dec 29, 2023 394.28 Mn
Sep 29, 2023 376.82 Mn
Jun 30, 2023 339.62 Mn
Mar 31, 2023 327.60 Mn
Dec 30, 2022 324.36 Mn
Sep 30, 2022 301.73 Mn
Jul 1, 2022 304.52 Mn
Apr 1, 2022 289.08 Mn
Dec 31, 2021 337.59 Mn
Oct 1, 2021 269.51 Mn
Jul 2, 2021 255.33 Mn